JabezDolz

NVCR ready to go on an extended run

ロング
NASDAQ:NVCR   NovoCure Limited
Initial Target by Apr 14 = 99
Target Range by 5/20/2022 = 108-116

Upcoming earnings as a catalyst. Bullish Momentum for pre-earnings run up.

Kept the chart simple but a lot of bullish aspects at play here, to name a few:

- ready for markup coming off an accumulation phase
- completes wave 5 correction apprx. .786 off the highs last June
- if you look at the bigger structure it just completed a running flat beginning Aug 2019

Great Company!
免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。